Webinar: Adjuvanted Mucosal Subunit Vaccine for Preventing SARS-CoV-2 Transmission and Infection

Webinar on March 13th

Register to attend a free NCI webinar. Attendees will learn about a new adjuvanted subunit mucosal Covid-19 vaccine. Study results show that this new vaccine prevents SARS-CoV-2 transmission and infection. Most SARS-CoV-2 vaccines focus on delivering immunization through an intramuscular injection. This new technology combines an initial intramuscular injection with subsequent intranasal boost administration of a novel, molecular adjuvant nanoparticle formulation.

The Presenter

Jay Berzofsky, M.D., Ph.D.
Chief, Vaccine Branch
Center for Cancer Research
National Cancer Institute

Dr. Jay Berzofsky, NCI Center for Cancer Research

Competitive Advantages

  • Stimulates both systemic and mucosal immunity; induces both humoral and cellular immunity, as well as trained innate immunity.
  • Leads to more effective virus clearance from the upper respiratory tract from which it could spread.
  • Stimulates sustained immune response.
  • Protects against SARS-CoV-2 variants.
  • Prevents or reduces onward transmission to others, addressing an important public health need.
  • Avoids painful injection with intranasal administration .
  • Notable improvement for manufacturing yield and cost, ease of administration, and distribution as compared to current candidates.

Commercial Applications:

  • Adjuvanted mucosal subunit vaccines (as single agents)
  • Vaccine composition(s)
  • Co-administration to enhance the effect of systemic immunization.

Why Attend?

  • Assess co-developing the technology.
  • Interact with the inventor, ask questions and provide feedback.
  • Learn how to partner with the NCI and NIH.


Who Should Attend?

  • Business development professionals
  • Drug development professionals
  • Investors and entrepreneurs
  • Biotech/pharma/academia researchers

xIf you cannot attend, you can view further information and licensing contact information on the Adjuvanted Mucosal Subunit Vaccines for Preventing SARS-CoV-2 Transmission and Infection abstract